SOYUZ "MEDIKO-FARMATSEVTICHESKIE PROEKTY. XXI VEK", Saint Petersburg

Economic indicators

Net profit (RAS) of SOYUZ MEDIKO-FARMATSEVTICHESKIE PROEKTY. XXI VEK made up 0 RUB over 2020 compared to 2.00 thousand RUB over 2019, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 7.91 million RUB in 2019; sales profit made up 0 RUB compared to 26.00 thousand RUB.

Net profit (RAS) of SOYUZ MEDIKO-FARMATSEVTICHESKIE PROEKTY. XXI VEK dropped in 2019 42.50 times to 2.00 thousand RUB from 85.00 thousand RUB over the same period in 2018, the company informed.

Revenue decreased in the accounting period by 9.25% to 7.91 million RUB from 8.71 million RUB in 2018; sales profit matched the previous year’s result amounting to 26.00 thousand RUB.

Net profit (RAS) of SOYUZ MEDIKO-FARMATSEVTICHESKIE PROEKTY. XXI VEK dropped in 2018 by 41.38% to 68.00 thousand RUB from 116.00 thousand RUB over the same period in 2017, the company informed.

Revenue increased in the accounting period by 30.97% to 8.71 million RUB from 6.65 million RUB over 2017; cost of goods sold decreased Infinity times to 0.00 thousand RUB from 4.14 million RUB; sales profit fell 10.62 times to 26.00 thousand RUB from 276.00 thousand RUB.

Net profit (RAS) of SOYUZ MEDIKO-FARMATSEVTICHESKIE PROEKTY. XXI VEK grew over 2017 2.27 times to 116.00 thousand RUB from 51.00 thousand RUB over 2016, the company informed.

Revenue decreased in the accounting period by 20.10% to 6.65 million RUB from 8.33 million RUB in 2016; cost of goods sold decreased by 47.37% to 4.14 million RUB from 7.87 million RUB; sales profit went up 1.84 times to 276.00 thousand RUB from 150.00 thousand RUB.

Net profit (RAS) of SOYUZ MEDIKO-FARMATSEVTICHESKIE PROEKTY. XXI VEK dropped in 2016 2.12 times to 51.00 thousand RUB from 108.00 thousand RUB over the same period in 2015, the company informed.

Revenue decreased in the accounting period by 14.12% to 8.33 million RUB from 9.69 million RUB in 2015; cost of goods sold decreased by 11.01% to 7.87 million RUB from 8.84 million RUB; sales profit fell by 27.18% to 150.00 thousand RUB from 206.00 thousand RUB.

Net profit (RAS) of NP Mediko-farmatsevticheskie proekty. XXI vek made up 45.00 thousand RUB over 2013 compared to net loss of 147.00 thousand RUB over 2012, the company informed.

Revenue increased in the accounting period 1.91 times to 5.49 million RUB from 2.88 million RUB over 2012; cost of goods sold grew 1.82 times to 5.51 million RUB from 3.02 million RUB; sales loss decreased 10.77 times to 13.00 thousand RUB from 140.00 thousand RUB.

Companies in the region

• GK SLAVIYA
• FAVORITINTER
• POLIMER
• FLAGMA KOMPANI
• AY SI ENERDZHI